Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Thum

Showing results (21-30 of 500) with videos related to

Pageof 50
Sort By:
Cell Research|April 24, 2013
miRNAGE-34 induces cardiac damAGECostanza Emanueli, Thomas Thum
Archives of Toxicology|September 14, 2007
Detection of early signals of hepatotoxicity by gene expression profiling studies with cultures of metabolically competent human hepatocytesThomas Thum, Jürgen Borlak
Current Drug Targets|April 27, 2010
MicroRNA-21: from cancer to cardiovascular diseaseVirginija Jazbutyte, Thomas Thum
Vascular Pharmacology|August 2, 2011
MicroRNAs and vascular (dys)functionDorothee Hartmann, Thomas Thum
Circulation Research|July 23, 2011
Biogenesis and regulation of cardiovascular microRNAsJohann Bauersachs, Thomas Thum
Arteriosclerosis, Thrombosis, and Vascular Biology|October 21, 2011
MicroRNAs looping around angiogenesisJan Fiedler, Thomas Thum
European Heart Journal|July 6, 2019
A new diastolic dysfunction disease-modelling platformShambhabi Chatterjee, Thomas Thum
Arteriosclerosis, Thrombosis, and Vascular Biology|May 16, 2014
The smooth long noncoding RNA SENCRThomas Thum, Regalla Kumarswamy
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 20, 2019
The Janus Face of miR-148a in Cardiac Remodeling and Heart FailureLisa Hobuß, Thomas Thum
Journal of Cachexia, Sarcopenia and Muscle|October 4, 2011
Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!Thomas Thum, Jochen Springer
Pageof 50

Showing results (21-30 of 500) with videos related to

Sort By:
Pageof 50
Cell Research|April 24, 2013
miRNAGE-34 induces cardiac damAGECostanza Emanueli, Thomas Thum
Archives of Toxicology|September 14, 2007
Detection of early signals of hepatotoxicity by gene expression profiling studies with cultures of metabolically competent human hepatocytesThomas Thum, Jürgen Borlak
Current Drug Targets|April 27, 2010
MicroRNA-21: from cancer to cardiovascular diseaseVirginija Jazbutyte, Thomas Thum
Vascular Pharmacology|August 2, 2011
MicroRNAs and vascular (dys)functionDorothee Hartmann, Thomas Thum
Circulation Research|July 23, 2011
Biogenesis and regulation of cardiovascular microRNAsJohann Bauersachs, Thomas Thum
Arteriosclerosis, Thrombosis, and Vascular Biology|October 21, 2011
MicroRNAs looping around angiogenesisJan Fiedler, Thomas Thum
European Heart Journal|July 6, 2019
A new diastolic dysfunction disease-modelling platformShambhabi Chatterjee, Thomas Thum
Arteriosclerosis, Thrombosis, and Vascular Biology|May 16, 2014
The smooth long noncoding RNA SENCRThomas Thum, Regalla Kumarswamy
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 20, 2019
The Janus Face of miR-148a in Cardiac Remodeling and Heart FailureLisa Hobuß, Thomas Thum
Journal of Cachexia, Sarcopenia and Muscle|October 4, 2011
Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!Thomas Thum, Jochen Springer
Pageof 50